| EER | ENST | ENSG | GeneName | Region | Repeat | dsRNA structure | | chr16:57773507-57774693:- | ENST00000564204.1 | ENSG00000140859.14 | KIFC3 | ncRNA_exonic | AluJr | chr16:57773507-57774693:-.alignment |
| chr16:57779589-57781350:- | ENST00000563295.1 | ENSG00000140859.14 | KIFC3 | ncRNA_exonic | (AAAT)n,AluSx,AluJo,THE1D,L1MB3,AluSz | chr16:57779589-57781350:-.alignment |
| chr16:57782660-57783801:- | ENST00000566975.4 | ENSG00000140859.14 | KIFC3 | ncRNA_intronic | AluSq2,L1MB7,AluSq | chr16:57782660-57783801:-.alignment |
| chr16:57782660-57783801:- | ENST00000567204.4 | ENSG00000140859.14 | KIFC3 | ncRNA_intronic | AluSq2,L1MB7,AluSq | chr16:57782660-57783801:-.alignment |
| chr16:57789750-57791232:- | ENST00000566975.4 | ENSG00000140859.14 | KIFC3 | ncRNA_exonic | AluSz,(T)n,AluJb,AluSx,MIR | chr16:57789750-57791232:-.alignment |
| chr16:57794309-57794556:- | ENST00000566914.1 | ENSG00000140859.14 | KIFC3 | ncRNA_intronic | AluJo | chr16:57794309-57794556:-.alignment |
| chr16:57794309-57794556:- | ENST00000566975.4 | ENSG00000140859.14 | KIFC3 | ncRNA_intronic | AluJo | chr16:57794309-57794556:-.alignment |
| chr16:57794309-57794556:- | ENST00000567204.4 | ENSG00000140859.14 | KIFC3 | ncRNA_intronic | AluJo | chr16:57794309-57794556:-.alignment |
| ID_events | cancer | TypeID | ImmuneCell | P | R | CorrelationPlot |
| chr16:57773507-57774693:- | BLCA | EER | Plasma_cells | 1.2845e-02 | 0.4418 |  |
| ENSG00000140859.14,KIFC3 | BLCA | EAG | T_cells_CD4_memory_activated | 1.8963e-02 | -0.2997 |  |
| ENSG00000140859.14,KIFC3 | BRCA | EAG | NK_cells_activated | 2.5509e-02 | -0.2957 |  |
| chr16:57773507-57774693:- | CESC | EER | T_cells_regulatory_(Tregs) | 9.7412e-03 | 0.4141 | .chr16_57773507-57774693_-.png) |
| ENSG00000140859.14,KIFC3 | CESC | EAG | T_cells_CD4_memory_resting | 8.6329e-03 | 0.3418 |  |
| chr16:57773507-57774693:- | CHOL | EER | T_cells_gamma_delta | 3.5639e-02 | -0.4606 |  |
| chr16:57773507-57774693:- | ESCA | EER | NK_cells_resting | 2.5480e-02 | -0.2597 |  |
| chr16:57779589-57781350:- | ESCA | EER | T_cells_CD4_naive | 1.4836e-03 | 0.3021 |  |
| chr16:57782660-57783801:- | ESCA | EER | Dendritic_cells_resting | 2.1206e-02 | 0.2790 |  |
| chr16:57789750-57791232:- | ESCA | EER | Macrophages_M1 | 3.2755e-02 | -0.2148 |  |
| chr16:57773507-57774693:- | HNSC | EER | T_cells_CD8 | 7.8687e-03 | 0.4758 |  |
| ENSG00000140859.14,KIFC3 | HNSC | EAG | Macrophages_M2 | 6.1482e-03 | -0.2792 |  |
| ENSG00000140859.14,KIFC3 | KIRC | EAG | Neutrophils | 2.9218e-02 | -0.1805 |  |
| ENSG00000140859.14,KIFC3 | KIRP | EAG | B_cells_naive | 1.4974e-02 | -0.2516 |  |
| ENSG00000140859.14,KIFC3 | LIHC | EAG | Mast_cells_resting | 4.8179e-02 | -0.2405 |  |
| chr16:57779589-57781350:- | LUAD | EER | T_cells_gamma_delta | 9.6172e-04 | 0.4091 |  |
| chr16:57782660-57783801:- | LUAD | EER | T_cells_CD4_memory_activated | 5.1739e-03 | 0.5744 |  |
| chr16:57789750-57791232:- | LUAD | EER | Dendritic_cells_resting | 8.9286e-03 | -0.2276 |  |
| chr16:57773507-57774693:- | LUSC | EER | Mast_cells_resting | 9.4190e-03 | 0.4389 |  |
| ENSG00000140859.14,KIFC3 | LUSC | EAG | Mast_cells_resting | 5.1132e-03 | 0.3513 |  |
| chr16:57789750-57791232:- | OV | EER | Macrophages_M0 | 2.4700e-02 | -0.2664 |  |
| ENSG00000140859.14,KIFC3 | OV | EAG | T_cells_CD4_memory_resting | 2.3509e-02 | 0.2547 |  |
| chr16:57773507-57774693:- | PAAD | EER | NK_cells_resting | 3.2648e-02 | -0.3977 |  |
| chr16:57773507-57774693:- | SKCM | EER | Plasma_cells | 2.9761e-03 | 0.4525 |  |
| ENSG00000140859.14,KIFC3 | SKCM | EAG | T_cells_regulatory_(Tregs) | 3.0154e-02 | -0.2238 | .ENSG00000140859.14,KIFC3.png) |
| chr16:57779589-57781350:- | STAD | EER | T_cells_gamma_delta | 1.5495e-02 | 0.1849 |  |
| chr16:57782660-57783801:- | STAD | EER | NK_cells_resting | 4.3438e-03 | 0.3301 |  |
| chr16:57789750-57791232:- | STAD | EER | B_cells_memory | 3.7755e-05 | 0.3287 |  |
| ENSG00000140859.14,KIFC3 | STAD | EAG | B_cells_memory | 1.4980e-02 | 0.1654 |  |
| chr16:57773507-57774693:- | THCA | EER | Dendritic_cells_resting | 2.0501e-02 | 0.2105 |  |
| ID_events | cancer | HallmarkType | Type | P | R | CorrelationPlot |
| ENSG00000140859.14,KIFC3 | BLCA | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 4.7783e-07 | -0.5929 |  |
| chr16:57773507-57774693:- | BLCA | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EER | 2.8528e-02 | -0.3935 |  |
| chr16:57773507-57774693:- | BRCA | GSVA_HALLMARK_KRAS_SIGNALING_DN | EER | 4.1206e-02 | 0.4288 |  |
| chr16:57789750-57791232:- | BRCA | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EER | 3.2952e-02 | 0.3514 |  |
| chr16:57773507-57774693:- | CESC | GSVA_HALLMARK_PANCREAS_BETA_CELLS | EER | 4.7034e-02 | 0.3242 |  |
| ENSG00000140859.14,KIFC3 | CESC | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 5.9039e-04 | -0.4377 |  |
| chr16:57773507-57774693:- | ESCA | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 1.7178e-02 | -0.2763 |  |
| chr16:57789750-57791232:- | ESCA | GSVA_HALLMARK_ADIPOGENESIS | EER | 2.2154e-02 | 0.2298 |  |
| chr16:57782660-57783801:- | ESCA | GSVA_HALLMARK_MYOGENESIS | EER | 9.8822e-03 | 0.3108 |  |
| ENSG00000140859.14,KIFC3 | ESCA | GSVA_HALLMARK_PEROXISOME | EAG | 1.5736e-03 | 0.2756 |  |
| chr16:57773507-57774693:- | HNSC | GSVA_HALLMARK_INFLAMMATORY_RESPONSE | EER | 4.0787e-02 | 0.3756 |  |
| ENSG00000140859.14,KIFC3 | HNSC | GSVA_HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY | EAG | 1.1004e-03 | -0.3298 |  |
| chr16:57773507-57774693:- | KIRC | GSVA_HALLMARK_BILE_ACID_METABOLISM | EER | 1.2042e-02 | 0.2305 |  |
| ENSG00000140859.14,KIFC3 | KIRC | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EAG | 5.5010e-04 | -0.2825 |  |
| chr16:57773507-57774693:- | KIRP | GSVA_HALLMARK_ANDROGEN_RESPONSE | EER | 9.9684e-03 | 0.3224 |  |
| ENSG00000140859.14,KIFC3 | KIRP | GSVA_HALLMARK_KRAS_SIGNALING_DN | EAG | 5.4053e-04 | -0.3520 |  |
| ENSG00000140859.14,KIFC3 | LIHC | GSVA_HALLMARK_UV_RESPONSE_UP | EAG | 3.9287e-05 | -0.4769 |  |
| chr16:57782660-57783801:- | LUAD | GSVA_HALLMARK_SPERMATOGENESIS | EER | 9.8077e-03 | 0.5380 |  |
| chr16:57779589-57781350:- | LUAD | GSVA_HALLMARK_ALLOGRAFT_REJECTION | EER | 4.2626e-02 | -0.2583 |  |
| chr16:57773507-57774693:- | LUAD | GSVA_HALLMARK_PEROXISOME | EER | 2.0494e-02 | 0.1797 |  |
| ENSG00000140859.14,KIFC3 | LUAD | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EAG | 4.3322e-05 | -0.2566 |  |
| chr16:57789750-57791232:- | LUAD | GSVA_HALLMARK_APOPTOSIS | EER | 2.3053e-03 | -0.2641 |  |
| ENSG00000140859.14,KIFC3 | LUSC | GSVA_HALLMARK_UV_RESPONSE_UP | EAG | 9.9025e-05 | -0.4742 |  |
| chr16:57773507-57774693:- | LUSC | GSVA_HALLMARK_UV_RESPONSE_DN | EER | 7.9116e-04 | 0.5481 |  |
| ENSG00000140859.14,KIFC3 | OV | GSVA_HALLMARK_XENOBIOTIC_METABOLISM | EAG | 3.6907e-03 | -0.3230 |  |
| chr16:57789750-57791232:- | OV | GSVA_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | EER | 1.6178e-02 | -0.2845 |  |
| ENSG00000140859.14,KIFC3 | PAAD | GSVA_HALLMARK_ADIPOGENESIS | EAG | 1.8821e-06 | -0.6376 |  |
| chr16:57773507-57774693:- | PAAD | GSVA_HALLMARK_ESTROGEN_RESPONSE_LATE | EER | 2.3323e-02 | -0.4200 |  |
| chr16:57773507-57774693:- | SKCM | GSVA_HALLMARK_INTERFERON_ALPHA_RESPONSE | EER | 4.8401e-02 | 0.3102 |  |
| ENSG00000140859.14,KIFC3 | SKCM | GSVA_HALLMARK_UV_RESPONSE_UP | EAG | 1.6414e-03 | -0.3204 |  |
| chr16:57782660-57783801:- | STAD | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EER | 2.6147e-02 | 0.2603 |  |
| chr16:57779589-57781350:- | STAD | GSVA_HALLMARK_WNT_BETA_CATENIN_SIGNALING | EER | 1.8959e-02 | 0.1793 |  |
| ENSG00000140859.14,KIFC3 | STAD | GSVA_HALLMARK_INFLAMMATORY_RESPONSE | EAG | 1.0940e-02 | -0.1728 |  |
| chr16:57773507-57774693:- | STAD | GSVA_HALLMARK_OXIDATIVE_PHOSPHORYLATION | EER | 1.9737e-02 | 0.2570 |  |
| chr16:57789750-57791232:- | STAD | GSVA_HALLMARK_MITOTIC_SPINDLE | EER | 1.8171e-02 | -0.1920 |  |
| ENSG00000140859.14,KIFC3 | THCA | GSVA_HALLMARK_MYC_TARGETS_V1 | EAG | 1.2129e-03 | -0.2393 |  |
| chr16:57773507-57774693:- | THCA | GSVA_HALLMARK_MYC_TARGETS_V2 | EER | 8.6638e-03 | 0.2377 |  |
| ID_events | cancer | Drug | Type | P | R | CorrelationPlot |
| chr16:57773507-57774693:- | BLCA | Gefitinib | EER | 4.5344e-03 | -0.4961 |  |
| ENSG00000140859.14,KIFC3 | BLCA | CGP.082996 | EAG | 1.6575e-04 | 0.4640 |  |
| chr16:57789750-57791232:- | BRCA | GDC.0449 | EER | 2.4726e-02 | 0.3687 |  |
| chr16:57773507-57774693:- | BRCA | Gefitinib | EER | 1.3648e-02 | 0.5065 |  |
| ENSG00000140859.14,KIFC3 | BRCA | AZD.2281 | EAG | 9.6343e-04 | 0.4257 |  |
| ENSG00000140859.14,KIFC3 | CESC | A.770041 | EAG | 1.9966e-04 | 0.4697 |  |
| chr16:57773507-57774693:- | CHOL | AZD7762 | EER | 1.4404e-03 | 0.6495 |  |
| ENSG00000140859.14,KIFC3 | CHOL | BIBW2992 | EAG | 1.1517e-02 | -0.5067 |  |
| chr16:57794309-57794556:- | ESCA | EHT.1864 | EER | 4.1909e-02 | 0.2918 |  |
| ENSG00000140859.14,KIFC3 | ESCA | BX.795 | EAG | 4.4343e-03 | 0.2490 |  |
| chr16:57779589-57781350:- | ESCA | ABT.263 | EER | 6.5592e-03 | 0.2613 |  |
| chr16:57782660-57783801:- | ESCA | CHIR.99021 | EER | 1.1322e-03 | -0.3865 |  |
| chr16:57789750-57791232:- | ESCA | AZ628 | EER | 6.2537e-03 | -0.2730 |  |
| chr16:57773507-57774693:- | HNSC | AZD6482 | EER | 8.8910e-03 | -0.4693 |  |
| ENSG00000140859.14,KIFC3 | HNSC | Bortezomib | EAG | 1.5367e-02 | 0.2480 |  |
| chr16:57773507-57774693:- | KIRC | JNK.Inhibitor.VIII | EER | 8.3734e-03 | 0.2417 |  |
| ENSG00000140859.14,KIFC3 | KIRC | CMK | EAG | 1.1875e-03 | 0.2657 |  |
| chr16:57773507-57774693:- | KIRP | AMG.706 | EER | 7.4462e-03 | 0.3341 |  |
| ENSG00000140859.14,KIFC3 | KIRP | Dasatinib | EAG | 2.6039e-03 | 0.3120 |  |
| ENSG00000140859.14,KIFC3 | LIHC | MG.132 | EAG | 3.7335e-03 | 0.3630 |  |
| chr16:57773507-57774693:- | LUAD | DMOG | EER | 2.6630e-02 | -0.1721 |  |
| ENSG00000140859.14,KIFC3 | LUAD | Gemcitabine | EAG | 1.3042e-03 | 0.2030 |  |
| chr16:57779589-57781350:- | LUAD | IPA.3 | EER | 4.4719e-02 | -0.2623 |  |
| chr16:57782660-57783801:- | LUAD | GSK269962A | EER | 3.8905e-04 | -0.6892 |  |
| chr16:57789750-57791232:- | LUAD | BIBW2992 | EER | 7.0414e-03 | 0.2344 |  |
| ENSG00000140859.14,KIFC3 | LUSC | CI.1040 | EAG | 1.0008e-03 | 0.4078 |  |
| chr16:57773507-57774693:- | LUSC | CMK | EER | 1.0176e-03 | 0.5385 |  |
| ENSG00000140859.14,KIFC3 | OV | AG.014699 | EAG | 1.4288e-02 | -0.2747 |  |
| chr16:57789750-57791232:- | OV | Docetaxel | EER | 9.5413e-03 | 0.3056 |  |
| ENSG00000140859.14,KIFC3 | PAAD | BIRB.0796 | EAG | 5.5399e-03 | -0.4026 |  |
| chr16:57773507-57774693:- | PAAD | AZD.0530 | EER | 3.9637e-02 | 0.4226 |  |
| ENSG00000140859.14,KIFC3 | SKCM | BAY.61.3606 | EAG | 4.8749e-03 | -0.2880 |  |
| ENSG00000140859.14,KIFC3 | STAD | Lenalidomide | EAG | 2.0006e-03 | -0.2091 |  |
| chr16:57773507-57774693:- | STAD | Embelin | EER | 2.3446e-03 | 0.3315 |  |
| chr16:57789750-57791232:- | STAD | Gefitinib | EER | 7.9257e-03 | -0.2168 |  |
| chr16:57779589-57781350:- | STAD | JNJ.26854165 | EER | 8.0231e-04 | 0.2540 |  |
| ENSG00000140859.14,KIFC3 | THCA | ATRA | EAG | 2.0121e-04 | -0.2744 |  |
| chr16:57773507-57774693:- | THCA | Axitinib | EER | 7.3478e-03 | 0.2426 |  |